Toxoplasma gondii vaccine

Drug Profile

Toxoplasma gondii vaccine

Alternative Names: Toxoplasmosis vaccine

Latest Information Update: 17 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; National Institutes of Health (USA)
  • Class Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Toxoplasmosis

Most Recent Events

  • 17 Jan 2007 Discontinued - Preclinical for Toxoplasmosis in United Kingdom (unspecified route)
  • 17 Jan 2007 Discontinued - Preclinical for Toxoplasmosis in USA (unspecified route)
  • 09 Apr 2002 An animal study has been added to the Parasitic Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top